Raised expression of gp130 (one of the two subunits of the IL-6 receptor) has been found on CD4+ T cells and B cells from patients with active SLE, while an important reduction in the gp130 expression by B lymphocytes was observed upon immunosuppressive treatment leading to milder disease activity [89]. This evidence concerns the gene CD4 and systemic lupus erythematosus.